I certainly don’t want a buyout and I have a hard time believing CytoDyn’s team wants one either after doing all the heavy lifting!
But, any legitimate offer has to be taken to the BOD to review the merits and determine if the deal structure is advantageous for shareholders. Regardless of what the simpletons have said about the management team, I believe their intentions are to maximize shareholder value while simultaneously saving as many lives as possible. As such, I believe any decision (funding, buyout, uplisting, etc...) will come down to those two primary drivers.
“So many people along the way,whatever it is you aspire to do, will tell you it can't be done. But all it takes is imagination. You dream. You plan. You reach. There will be obstacles. There will doubters. There will be mistakes. But with hard work, with belief, with confidence and trust in yourself and those around you, there no limits.” -Michael Phelps